GB2354518A - Porous ceramic bodies; bone cell growth and drug carriers - Google Patents

Porous ceramic bodies; bone cell growth and drug carriers Download PDF

Info

Publication number
GB2354518A
GB2354518A GB0100084A GB0100084A GB2354518A GB 2354518 A GB2354518 A GB 2354518A GB 0100084 A GB0100084 A GB 0100084A GB 0100084 A GB0100084 A GB 0100084A GB 2354518 A GB2354518 A GB 2354518A
Authority
GB
United Kingdom
Prior art keywords
pores
micrometre
bone
porous ceramic
size range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0100084A
Other versions
GB0100084D0 (en
GB2354518B (en
Inventor
Robert Terence Smith
Rodney Martin Sambrook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dytech Corp Ltd
Original Assignee
Dytech Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dytech Corp Ltd filed Critical Dytech Corp Ltd
Priority to GB0100084A priority Critical patent/GB2354518B/en
Publication of GB0100084D0 publication Critical patent/GB0100084D0/en
Publication of GB2354518A publication Critical patent/GB2354518A/en
Application granted granted Critical
Publication of GB2354518B publication Critical patent/GB2354518B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/0038Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by superficial sintering or bonding of particulate matter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/06Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances
    • C04B38/0615Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles
    • C04B38/062Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles the burned-out substance being formed in situ, e.g. by polymerisation of a prepolymer composition containing ceramic powder
    • C04B38/0625Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles the burned-out substance being formed in situ, e.g. by polymerisation of a prepolymer composition containing ceramic powder involving a foaming step of the burnable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Porous Artificial Stone Or Porous Ceramic Products (AREA)

Abstract

A porous ceramic body is made of bonded particles and has a defined pore size and true porosity. The pores may be infilled with bone cells or drugs. It is made by a process in which the body is fired at 125{C or 135{C for two hours.

Description

2354518 Agents ref.. P0301 I GB A POROUS CERAMIC BODY COMPOSED OF BONDED
PARTICLES The invention relates to a porous ceramic body composed of bonded particles and having predetermined physical properties.
GB-A-2142929 discloses a porous ceramic body for use, e.g. in bone regeneration and having pores in the size range of I to 600 micrometre, wherein some pores are connected to the exterior of the body via capillary voids.
US-A-5011495 discloses a 'disc' body for use in the promotion of bone growth comprising layers of porous tricalcium phosphate having randomly occurring nonconnected pores the majority of which are in the size range of 70 tO 420 micron.
It is one object of the invention to provide a method of making a porous article having controlled levels of porosity, interconnectivity, pore size, and mechanical properties suitable for use in various applications.
In one aspect the invention provides a porous ceramic body composed of bonded particles, having interconnected pores in the size range of at least 15 micrometre and a true porosity in the range of from about 20% to about 95% and which has been fired at 1250'C for two hours.
2 In another aspect the invention provides a porous ceramic body composed of bonded particles, having interconnected pores in the size range of at least 15 micrometre and a true porosity of from about 20% to about 95% and which has been fired at 1350'C for two hours.
In one preferred embodiment the pores are in the size range of 15 to 50 micrometre for use in encouraging fibrovascular ingrowth.
In another preferred embodiment the pores are in the size range of 50 to 150 micrometre for osteoid formation.
In another preferred embodiment the pores are in the size range greater than 150 micrometre to facilitate ingrowth of mineralised bone.
In yet another preferred embodiment the pores are infilled with bone cells or a drug.
The particles will be chosen according to the intended end use. As will be explained later, for the preferred use hydroxyapatite is present either alone or with other particles. The other particles can include both oxides and non-oxides such as alumina, mullite, silicon carbide, silicon nitride, zirconia, titanium oxide and the like. Preferably the particles have an average particle size less than about 5 micrometres and Preferably 95% of the particles will be less than about 2 micrometres. However, the particles can be much larger, say 100 micrometres or more.
3 It is a feature of the invention that the final articles formed consist essentially of the starting ceramic materials only, so avoiding the need for the removal of residual secondary e.g. inorganic binders. The article can thus consist of ingredients acceptable for medical use, e.g. as bone grafts for orthopaedic, surgical, dental and like uses both for humans and animals. There will always be a need to replace bone lost as a consequence of traumatic or non-traumatic events. Bone substitute materials are available and approved for clinical use. These materials have been successfully used in orthopaedics, dentistry and facial plastic surgery. Among the types of bone graft materials used, particular interest has been shown in the porous types which can provide a scaffold for in growth of connective tissue and bone. Studies have shown that pore sizes less than 10 micrometre prevent ingrowth of cells, pore sizes of 15 to 50 micrometre encourages fibrovascular ingrowth; pore sizes of 50-150 micrometre result in osteoid formation; and pore sizes greater than 150 micrometre facilitate the ingrowth of mineralized bone. Different approaches have been taken to try and mimic the hydroxyapatite frame work within both the cortical and cancellous bone. One material is based on the conversion of a coralline structure to hydroxyapatite material. With this process the selection of the coral with the correct pore structure is imperative before conversion takes place. Two corals were eventually selected exhibiting two different pore structures. These two pore structures are intended to replicate the different structures in cortical and cancellous bone. It is a feature of this invention that synthetic articles made by the method may be used as bone graft materials of high acceptability.
Hydroxyapatite [Ca10(P04), (OH)21 is an ideal candidate starting material. This material belongs to a group of calcium phosphates which are being considered as bone 4 substitute materials. The invention is applicable to hydroxyapatite and any other calcium phosphate (where the Ca/P atomic ratio may vary widely). In addition to this group of materials it may be advantageous to create an interconnected structure in another ceramic material such as alumina or zirconia for mechanical property reasons and either use the material as produced, or coated with a more bioactive material such as hydroxyapatite. It is another feature of this invention that the materials known as "Bioglass" could be converted in highly porous structures using this method.
The true porosity will range from about 20% to about 95%. The article formed is relatively robust after polymerisation and strong enough to be machined after removal of the liquid carrier.
The firing temperature and duration are selected according to the nature of the particles, e.g. alumina generally requires a higher sintering temperature than hydroxyapatite.
It is a feature of this invention to provide an article having a highly microporous structure if the sintering procedure is controlled. This microporous, structure can have advantages in certain applications e.g. it may be infilled with certain drugs such as antibiotics or growth factors, to act as a slow release agent at the site of an implant and it appears to encourage the easy attachment of in-growing bone cells compared to a dense microstructure.
The formed article may be in a variety of shapes, e.g. in the form of granules, bars, cylinders or rods, blocks or the like.
In order that the invention may be well understood it will now be described by way of illustration only by reference to the following examples and micrographs. The method is described and claimed in our copending Application No. of even date herewith.
Example I
Hydroxyapatite powder, ammonium acrylate monomer, methylenebisacrylamide, water, the ammonium salt of polyacrylate and the ammonium salt of polymethacrylate were mixed together to form a slurry which was subjected to a high shear mixer in order to remove any agglomerates within the slurry. This was transferred to a glove box within which the oxygen concentration was approx. 0. 1 %. A surfactant TERGITOL TMN 10 was introduced into the slurry and the whole was agitated in a mixer designed to introduce air so that a foam will be formed. The amount by which the ceramic solid is foamed is dependant on the final density required, the solids content of the slurry and the shrinkage which will occur at the later stages of drying and firing. The amount of surfactant added determines the extent of foaming, and this was selected to achieve the required final density. Once the foam density was achieved, ammonium persulphate (initiator) and tetramethylethylenediamine (catalyst) were injected into the foam to cause the acrylate monomer to start to polymerise. The time before the onset of polymerisation was about 1.5 minutes.
The mixture was restirred and allowed to stand. Polymerisation. began after about 1.5 minutes. A photo of the microstructure produced after an idle time of 1.5 minutes is shown in Figure 2. Once polymerised the foam was removed from the mould and 6 allowed to dry at room temperature for 2 days before being forced dried at 600 C in an oven.
At this point the "green" ceramic can easily be machined into the desired shape. The t4green" article was heated in a furnace to remove the organic binder and to cause the ceramic microstructure to densify. The sample was split in two and fired at two different temperatures. Sample I shown in Figure 3 and sample 2 in Figure 4 were fired at 12500 C for 2 hrs and 13500 C for 2 hrs respectively. It can be seen that the degree of microstructural densification can be adjusted with the sintering conditions. Sample I exhibits a highly connected microstructure whereas the microstructural porosity has been removed in sample 2. Live human bone cells were cultured. Both samples I and 2 were immersed in the cultures and Figures 5 and 6 show the results after 36 hrs immersion for sample 1 and 2 respectively. The bone cells can be clearly seen on the surface of the cell walls. From these Figures it appears easier for the bone to grow within the undersintered, microstructure than the fully densified, structure.
Example Il
The method of Example I was repeated except that the rate of addition of the initiator and the catalyst were selected so that the time before onset of polymerisation was 16 minutes instead of 1.5 minutes. A highly porous foarn exhibiting a larger cell size as shown in Figure 7 resulted. It can be seen from the different Figures that the time before the onset of polyrnerisation has had a major influence on the cell structure.
The Figures of the accompanying drawings are microphotographs as follows:
7 Figure I is a general foam; Figure 2 is a foam produced in Example I taken after an idle time of 1.5 minutes; Figure 3 is the polyrnerised foam of Example I fired at 12500C for 2 hours; Figure 4 is the polyrnerised foam of Example I fired at 13500C for 2 hours; Figure 5 is the fired product shown in Figure 3 after being immersed in a bone cell culture for 36 hours; Figure 6 is the fired product shown in Figure 4 after being immersed in a bone cell culture for 36 hours; and Figure 7 is the foam produced in Example II.
8

Claims (6)

1. A porous ceramic body composed of bonded particles, having interconnected pores in the size range of at least 15 micrometre and a true porosity in the range of from about 20% to about 95% and which has been fired at 1250'C for two hours.
2. A porous ceramic body composed of bonded particles, having interconnected pores in the size range of at least 15 micrometre and a true porosity of from about 20% to about 95% and which has been fired at 13500C for two hours.
3. A body according to Claim 1 or 2, wherein the pores are in the size range of 15 to 50 micrometre for use in encouraging fibrovascular ingrowth.
4. A body according to Claim 1 or 2, wherein the pores are in the size range of 50 to 150 micrometre for osteoid formation.
4. A body according to Claim I or 2, wherein the P[ores are in the size range greater than 150 micrometre to facilitate ingrowth of mineralised bone.
5. A body according to any preceding Claim, wherein the pores are infilled with bone cells.
6. A body according to any of Claims I to 6, wherein the pores are infilled with a drug.
GB0100084A 1996-10-04 1996-10-04 A porous ceramic body composed of bonded particles Expired - Lifetime GB2354518B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0100084A GB2354518B (en) 1996-10-04 1996-10-04 A porous ceramic body composed of bonded particles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0100084A GB2354518B (en) 1996-10-04 1996-10-04 A porous ceramic body composed of bonded particles
GB9620752A GB2317887A (en) 1996-10-04 1996-10-04 Porous ceramic articles; bone cell growth and drug carriers

Publications (3)

Publication Number Publication Date
GB0100084D0 GB0100084D0 (en) 2001-02-14
GB2354518A true GB2354518A (en) 2001-03-28
GB2354518B GB2354518B (en) 2001-06-13

Family

ID=10800966

Family Applications (3)

Application Number Title Priority Date Filing Date
GB9620752A Withdrawn GB2317887A (en) 1996-10-04 1996-10-04 Porous ceramic articles; bone cell growth and drug carriers
GB0100084A Expired - Lifetime GB2354518B (en) 1996-10-04 1996-10-04 A porous ceramic body composed of bonded particles
GB0100085A Expired - Lifetime GB2354519B (en) 1996-10-04 1996-10-04 Production of porous ceramic articles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB9620752A Withdrawn GB2317887A (en) 1996-10-04 1996-10-04 Porous ceramic articles; bone cell growth and drug carriers

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0100085A Expired - Lifetime GB2354519B (en) 1996-10-04 1996-10-04 Production of porous ceramic articles

Country Status (5)

Country Link
EP (1) EP0958261A1 (en)
JP (1) JP2001501902A (en)
AU (1) AU4563997A (en)
GB (3) GB2317887A (en)
WO (1) WO1998015505A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10286102B2 (en) 2010-05-11 2019-05-14 Howmedica Osteonics Corp Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718672C1 (en) * 1997-05-02 1998-09-24 Zschimmer & Schwarz Gmbh & Co Use of a sugar
GB9821663D0 (en) * 1998-10-05 1998-11-25 Abonetics Ltd Foamed ceramics
GB9825109D0 (en) * 1998-11-16 1999-01-13 Dytech Corp Ltd Porous ceramic matrices
JP3400740B2 (en) 1999-04-13 2003-04-28 東芝セラミックス株式会社 Calcium phosphate porous sintered body and method for producing the same
AP1535A (en) * 1999-05-12 2006-01-09 D & E Cryo Cc Ceramic wound treatment device.
EP1108698B8 (en) * 1999-12-16 2006-10-04 IsoTis N.V. Porous ceramic body
AU778651B2 (en) 1999-12-16 2004-12-16 Isotis N.V. Porous ceramic body
US20020022885A1 (en) * 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
GB0019003D0 (en) * 2000-08-04 2000-09-20 Lo Wei Jen Porous synthetic bone graft and method of manufacture thereof
GB0020610D0 (en) * 2000-08-21 2000-10-11 Dytech Corp Ltd Uses of porous carriers
GB0020734D0 (en) * 2000-08-22 2000-10-11 Dytech Corp Ltd Bicontinuous composites
US6713420B2 (en) 2000-10-13 2004-03-30 Toshiba Ceramics Co., Ltd. Porous ceramics body for in vivo or in vitro use
JP4070951B2 (en) 2000-12-07 2008-04-02 ペンタックス株式会社 Method for producing porous calcium phosphate ceramic sintered body
EP1358132A4 (en) * 2000-12-21 2004-12-29 Corning Inc Refractories for fused silica production furnaces
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
DE10113108B4 (en) * 2001-03-15 2007-07-26 Dot Gmbh Active substance-containing calcium phosphate materials
EP1293220B1 (en) 2001-09-13 2006-11-08 Akira Myoi Porous calcium phosphate ceramics for in vivo use
AU2003256227A1 (en) * 2002-07-30 2004-02-16 Nanyang Technological University Spherical nano-composite powder and a method of preparing the same
DE10328892A1 (en) * 2003-06-26 2005-05-12 Curasan Ag Bone building agent and manufacturing process
JP4215595B2 (en) * 2003-08-21 2009-01-28 安正 赤川 Implant fixing member and implant composite material
WO2007086964A2 (en) 2005-10-21 2007-08-02 University Of South Florida Method of producing interconnected volumetric porosity in materials
US8916228B2 (en) 2007-08-09 2014-12-23 The Board Of Regents Of The University Of Texas System Bi-layered bone-like scaffolds
US8044105B2 (en) 2008-02-04 2011-10-25 Dow Global Technologies Llc Water-based ceramic foams showing improved gel strength
US8765189B2 (en) 2011-05-13 2014-07-01 Howmedica Osteonic Corp. Organophosphorous and multivalent metal compound compositions and methods
CN109512678B (en) * 2018-11-28 2022-04-08 福建工程学院 Preparation method of denture film

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2078696A (en) * 1980-05-28 1982-01-13 Mitsubishi Mining & Cement Co Porous Calcium Phosphate Body
GB2142919A (en) * 1983-07-09 1985-01-30 Sumitomo Cement Co Porous ceramic material and processes for preparing same
US4629464A (en) * 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute
US4846838A (en) * 1983-07-15 1989-07-11 Tdk Corporation Prosthetic body for bone substitute and a method for the preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3537947A (en) * 1967-05-18 1970-11-03 Uniroyal Inc Leather-like poromeric material and method for making the same
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
JPS56145153A (en) * 1980-03-05 1981-11-11 Toyo Tire & Rubber Co Manufacture of porous ceramic moldings
DK154260C (en) * 1981-02-20 1989-05-22 Mundipharma Gmbh PROCEDURE FOR THE MANUFACTURING OF A BONE IMPLANT OF FURNISHED TRICAL CUMPHOSPHATE, SPECIFICALLY FOR FILLING OF SPACES OR FOR COMPOSITION OF BONE PARTS AFTER FRACTURE.
US5011495A (en) * 1990-02-16 1991-04-30 The United States Of America As Represented By The Secretary Of The Army Unique bone regeneration tricalcium phosphate
WO1993004013A1 (en) * 1991-08-12 1993-03-04 Dytech Corporation Limited Porous articles
DE4313715A1 (en) * 1993-04-27 1994-11-03 Roehm Gmbh Highly filled, foamed polymer material
GB9409258D0 (en) * 1994-05-10 1994-06-29 Dytech Corp Ltd Production of ceramic articles
GB2289466B (en) * 1994-05-10 1997-10-22 Dytech Corp Ltd Production of porous refractory articles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2078696A (en) * 1980-05-28 1982-01-13 Mitsubishi Mining & Cement Co Porous Calcium Phosphate Body
GB2142919A (en) * 1983-07-09 1985-01-30 Sumitomo Cement Co Porous ceramic material and processes for preparing same
US4846838A (en) * 1983-07-15 1989-07-11 Tdk Corporation Prosthetic body for bone substitute and a method for the preparation thereof
US4629464A (en) * 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10286102B2 (en) 2010-05-11 2019-05-14 Howmedica Osteonics Corp Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods

Also Published As

Publication number Publication date
GB0100084D0 (en) 2001-02-14
WO1998015505A1 (en) 1998-04-16
GB2354519A (en) 2001-03-28
GB2354519A8 (en) 2001-07-19
AU4563997A (en) 1998-05-05
GB2354519B (en) 2001-06-13
GB2317887A (en) 1998-04-08
GB9620752D0 (en) 1996-11-20
GB0100085D0 (en) 2001-02-14
JP2001501902A (en) 2001-02-13
EP0958261A1 (en) 1999-11-24
GB2354518B (en) 2001-06-13

Similar Documents

Publication Publication Date Title
GB2354518A (en) Porous ceramic bodies; bone cell growth and drug carriers
US6479418B2 (en) Porous ceramic body
Tancred et al. A synthetic bone implant macroscopically identical to cancellous bone
US8613876B2 (en) Foamed ceramics
EP1024840B1 (en) Bone substitute materials
JP3362267B2 (en) Bioimplant material and method for producing the same
US5639402A (en) Method for fabricating artificial bone implant green parts
Li et al. Novel method to manufacture porous hydroxyapatite by dual‐phase mixing
JP2004505677A (en) Porous artificial bone graft and method for producing the same
Ebaretonbofa et al. High porosity hydroxyapatite foam scaffolds for bone substitute
Lee et al. Selective laser sintering of bioceramic materials for implants
Abdurrahim et al. Recent progress on the development of porous bioactive calcium phosphate for biomedical applications
Umemoto et al. In vivo bioresorbability and bone formation ability of sintered highly pure calcium carbonate granules
US8465582B2 (en) Process for producing inorganic interconnected 3D open cell bone substitutes
AU775040B2 (en) Composites
Swain Processing of porous hydroxyapatite scaffold
WO2001094274A1 (en) Foamed ceramics
US20040253279A1 (en) Production of porous articles
Hsu et al. Fabrication of porous calcium phosphate bioceramics as synthetic cortical bone graft
JP2003038636A (en) Porous ceramic member for living organism
EP1108698B1 (en) Porous ceramic body
Aizawa et al. Development and biological evaluation of apatite fibre scaffolds with large pore size and high porosity for bone regeneration
Hesaraki et al. Montmorillonite-added calcium phosphate bioceramic foams
ENDOPROSTHESIS OM Beketov National University of Urban Economy in Kharkiv